Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of 5-aminolevulinic acid plus sodium ferrous citrate in adults with type 2 diabetes mellitus
2017-004944-39Phase 2Completed
- Sponsor
- Neopharma Japan
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of 5-aminolevulinic acid and sodium ferrous citrate in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Neopharma Japan. Primary endpoint: Mean change from baseline in HbA1c to Week 24. Started Apr 2018; status: completed.
02
Drugs
5-aminolevulinic acidsodium ferrous citrate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2017-004944-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004944-39.